CREB3L2 and cancer: CREB3L2 is also mutated in thyroid carcinomas, where it is fused with peroxisome proliferator-activated receptor γ (PPARγ), a master regulator of fatty acid storage in adipocytes and glucose metabolism in cancer cells, to promote thyroid tumor growth [126].